HOME >> MEDICINE >> NEWS
Crohn's & Colitis Foundation of America selects Wiley to publish Inflammatory Bowel Diseases

Global publisher John Wiley & Sons, Inc., announced today that it has been selected by the Crohn's & Colitis Foundation of America (CCFA) as the new publisher of the Foundation's official journal, Inflammatory Bowel Diseases, effective January 2007.

Inflammatory Bowel Diseases is the first and only peer-reviewed journal dedicated exclusively to inflammatory bowel diseases. Now in its tenth year, the journal provides articles of interest to professionals treating patients and conducting research in this expanding field. Each issue contains articles on clinical and basic science, as well as reviews of treatments and ground-breaking research.

"This is a wonderful partnership opportunity for Wiley," said Shawn Morton, Wiley Vice President and Publishing Director, Medicine. "We look forward to facilitating communication about the mechanisms and treatment of Crohn's disease and ulcerative colitis through this premier publication in collaboration with CCFA."

Wiley will begin publishing the journal in 2007 and will continue to make it available in print and online as a benefit of CCFA Professional Membership, and through subscription to other individual and institutional customers. Inflammatory Bowel Diseases will be available online via Wiley InterScience (www.interscience.wiley.com), the company's online publishing platform.

"CCFA is extremely proud of this journal, which provides an important forum for the best and the brightest scientists and clinicians in our field to report on the advances that are being made," said Jonathan Braun, M.D., Ph.D., Professor, David Geffen School of Medicine, UCLA Medical Center, and Chair of CCFA's National Scientific Advisory Committee. "We're confident that our partnership with Wiley will allow us to build on the journal's success, and expand our outreach to the medical community."


'"/>

Contact: David Greenberg
dgreenbe@wiley.com
201-748-6484
John Wiley & Sons, Inc.
20-Mar-2006


Page: 1

Related medicine news :

1. ECP may be effective in treating Crohns disease
2. Smoking influences Crohns disease
3. Researchers identify new therapy for patients with Crohns disease
4. Canada high in ulcerative colitis and Crohns cases: Is Canada too clean?
5. Penn State research shows withdrawal drug offers relief for Crohns sufferers
6. Immune signals of variations of a single gene linked to more severe Crohns disease
7. Biologic therapies lead evolution of Crohns treatments
8. FDA grants priority review of Remicade® for children with Crohns disease
9. New insight into cause of Crohns disease
10. Improved diagnostic technology for Crohns disease
11. UVa Health System wins renewal of $6.2 million grant for Crohns disease research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a weight ... app plans to fix the two major problems leading the fitness industry today:, ... program , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American Institutes ... Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , ... advance care planning, healthcare costs and patient and family engagement. , AIR researchers ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June ... , brings up a new, often overlooked aspect of head lice: the parasite’s ability to ... is not a common occurrence, but a necessary one in the event that lice have ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June ... -based mobile pulmonary function testing company, is now able to ... devices developed by ndd Medical Technologies , Inc. ... done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ... , can get any needed testing done in the comfort of ...
(Date:6/24/2016)... -- According to a new market research ... Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, ... Purchase (Retail, Non-Retail) - Trends & Global Forecasts to ... for the forecast period of 2016 to 2021. This ... 2021 from USD 1.65 Billion in 2016, growing at ...
Breaking Medicine Technology:
Cached News: